Peptides LL37 5mg CAS:154947-66-7

Peptides LL37 5mg CAS:154947-66-7
Product Introduction:
LL37 is a multifunctional peptide molecule composed of members of the human antimicrobial peptide (AMP) family, with a wide range of immunomodulatory and antibacterial activities. It is composed of 37 amino acid residues and belongs to a type of natriuretic peptide (Cathelicidin). It is mainly synthesized by immune cells in the skin and upper respiratory tract and acts as part of the body's defense system. LL37 not only has significant anti-bacterial, anti-viral and anti-fungal capabilities, but also has a profound impact on the immune system by regulating immune responses. It interacts with the cell membranes of pathogenic microorganisms and destroys the integrity of the pathogenic cell membranes, thereby directly inhibiting the growth of microorganisms or causing their death. In addition, LL37 can also activate a series of immune responses by binding to immune cell receptors, promote local inflammatory responses, and regulate the migration and activity of immune cells such as leukocytes and macrophages. In terms of treatment, LL37 has become a potential therapeutic candidate for a variety of diseases, especially infectious diseases and immune system disorders, due to its multiple effects.
Send Inquiry
Description
Technical Parameters

 

Product Introduction

Name:LL37

Product Benefits:Promotes wound healing

CAS:154947-66-7

Capacity:5mg/vial

Product Form:White or off-white powder(Peptides)

Shelf Life:2-3Years(The product packaging date shall prevail)

What is the peptide LL37?

 

**LL-37** is a short peptide produced by the cleavage of human cathelicidin antimicrobial peptide (hCAP-18). Its main functions are antibacterial, antiviral, antifungal and immune response regulation. LL-37 is an important component of the immune system, especially in local immunity and defense mechanisms.

 

### Physical and chemical properties:

- **Molecular weight**: The molecular weight of LL-37 is approximately 4,100 Da.

- **Amino acid sequence**: LL-37 consists of 37 amino acids with the sequence **KKIISKFLHNLLPENIPKCSKSTGHKAFS**.

- **Structure**: LL-37 is a linear α-helical structure with a positive charge. It has strong hydrophilic and hydrophobic regions, can interact with the phospholipid bilayer of the cell membrane, and usually achieves its antibacterial effect by forming pores inserted into the membrane.

- **Charge**: Due to its rich content of positively charged amino acids (such as lysine and arginine), LL-37 has a strong positive charge (usually +6), which helps it interact with the negative charge of bacterial cell membranes.

 

### Main functions and effects:

1. **Antibacterial effect**: As a natural antimicrobial peptide, LL-37 is effective against a variety of bacteria, including Gram-positive and Gram-negative bacteria. Its mechanism of action is to inhibit bacterial growth or directly kill bacteria by inserting into the bacterial membrane, disrupting the structure of the cell membrane, and causing the leakage of cell contents.

2. **Antivavirus and antifungal effects**: LL-37 has also been found to have inhibitory effects on certain viruses (such as influenza virus) and fungi.

3. **Immunomodulation**: LL-37 can regulate immune responses, promote inflammatory responses, and regulate the functions of immune cells, such as enhancing the phagocytosis of macrophages or promoting the release of cytokines. It can also play an immunomodulatory role by binding to receptors of the immune system, helping to clear pathogens and restore tissue homeostasis.

4. **Wound healing**: LL-37 plays a role in the wound healing process, promoting epidermal cell proliferation, migration, and angiogenesis.

5. **Antitumor effect**: In some studies, LL-37 has been found to have potential antitumor effects, possibly by inducing tumor cell death or inhibiting tumor expansion.

 

### Dosage and use:

LL-37 is mainly used in medical research and clinical trials for the treatment of local infections, wound healing, immune regulation, etc., and is usually used in external forms (such as sprays, creams, etc.). LL-37 is also used as a research tool to explore its potential applications in immune regulation, antibacterial, antiviral, etc.

- **Dosage**: In clinical studies, the dosage of LL-37 varies according to the specific treatment purpose and administration method. Generally speaking, the topical dose usually ranges from a few micrograms to several hundred micrograms. For the treatment of wound healing and local infections, the dosage is usually adjusted by the doctor according to the specific situation of the patient.

- **Administration method**: LL-37 can be used by topical application, spray, soaking or injection. For systemic treatment, the application of LL-37 is still in the clinical trial stage and has not yet been widely used.

 

### Half-life and pharmacokinetics:

- **Half-life**: The half-life of LL-37 is usually short, about 1 to 2 hours, depending on its degradation and clearance rate in the body. Its short half-life is mainly due to its rapid degradation and clearance in the body, especially through renal excretion.

- **Metabolism and elimination**: The metabolism of LL-37 in the body is mainly carried out by enzyme degradation (such as proteases). Its renal excretion also plays an important role, usually excreted from the body by tubular filtration.

 

### Cycle and duration of action:

- **Short-term action**: The antibacterial effect of LL-37 usually takes effect within a few minutes to a few hours after administration. Because it works by interacting with cell membranes, the antibacterial effect is often rapid.

- **Long-term effect**: In terms of immunomodulation, the effect of LL-37 usually lasts for hours to days, depending on its local concentration and the persistence of the immune response. LL-37's promotion of wound healing usually takes days to weeks, especially in chronic wounds and difficult-to-heal tissues.

 

### Risks and Side Effects:

- **Immune System-Related Side Effects**: Due to LL-37's role in regulating the immune system, overdose may lead to an overactive immune response, such as inflammatory responses or autoimmune problems.

- **Local Reactions**: When LL-37 is used topically, minor side effects such as skin irritation, allergic reactions, or local redness and swelling may occur, especially in sensitive areas of the skin.

- **Systemic Side Effects**: When LL-37 is used systemically, allergic reactions may occur, especially when used for a long time or at high doses.

 

### Clinical and Research Applications:

The research on LL-37 focuses on its potential in anti-infection, immune regulation, wound healing, and anti-tumor. It is still in the clinical trial stage and has not yet become a common treatment. However, in some special cases, LL-37 has shown positive prospects as a local treatment, especially in patients with skin infections, chronic wounds, or immune deficiencies.

In general, LL-37, as a natural antimicrobial peptide, has a wide range of antimicrobial, immunomodulatory and repair effects, but due to its short half-life and rapid degradation rate, the dosage, frequency of use and potential side effects need to be carefully considered in clinical applications.

16

 

Peptide LL37 is suitable for people

 

LL-37 is a human antimicrobial peptide (AMPs) belonging to the defensin family. It plays an important role in the body's immune system. LL-37 can play an antibacterial, antiviral, anti-inflammatory, and promote wound healing effects in a variety of ways. The following is a detailed introduction to the applicable population, working principle, and usage and dosage of LL-37.

 

### 1. **Applicable population**

LL-37 has a wide range of applicable populations, mainly including:

- **Immune-impaired people**: such as the elderly, patients with diabetes, HIV infection, patients who use immunosuppressants for a long time, etc. These people have weak immune systems and are susceptible to bacteria, viruses and other pathogens.

- **Chronic inflammatory disease patients**: such as psoriasis, rheumatoid arthritis, allergic dermatitis, etc. The immune system of patients with these diseases is often in a hyperactive or disordered state. LL-37 can relieve symptoms by regulating immune response.

- **Skin disease patients**: such as eczema, burns, ulcers, chronic trauma, etc. LL-37 has the effect of promoting wound healing and inhibiting infection, so it has potential application value in the treatment of skin injuries.

- **Patients who need antibacterial and anti-inflammatory treatment**: LL-37 can be used to prevent and treat infections caused by various bacteria, fungi, and viruses. Especially when used topically, it can help reduce the occurrence of infections, especially wound infections and skin infections.

 

### 2. **Working Principle**

As an antimicrobial peptide, LL-37 mainly works through the following mechanisms:

- **Antibacterial effect**: LL-37 has a direct antibacterial effect and can destroy the bacterial cell membrane, causing the leakage of bacterial cell contents, thereby killing bacteria. It has antibacterial activity against a variety of pathogenic microorganisms (such as bacteria, fungi, viruses, etc.).

- **Immunomodulatory effect**: LL-37 can not only directly kill pathogenic microorganisms, but also regulate the host's immune response and promote the disappearance of inflammatory responses. When inflammation occurs, LL-37 can inhibit excessive immune responses and reduce tissue damage.

- **Promote wound healing**: LL-37 can promote fibroblast proliferation and angiogenesis, accelerating the wound healing process. In addition, it can also help restore the local immune environment by regulating cytokine levels.

- **Antiviral effect**: LL-37 can inhibit the invasion of viruses to a certain extent, especially by destroying the outer membrane of the virus or binding to the virus, thereby reducing its ability to infect.

 

### 3. **Usage and dosage**

The usage and dosage of LL-37 are usually adjusted according to the specific treatment purpose and patient condition. The following are several common application methods:

#### Topical application:

- **Indications**: Used for local infections (such as skin infections, trauma infections, post-burn care, etc.), allergic dermatitis, eczema and other skin diseases.

- **Usage**: LL-37 can be applied directly to the affected area or wound. When using, make sure the affected area is clean and dry, and avoid contact with the eyes or mucous membranes.

- **Dosage**: Usually apply 1-2 times each time, and 1-3 times a day as needed. The specific dosage should be adjusted according to the doctor's advice and specific circumstances.

#### Systemic application (oral or injection):

- **Indications**: Used to treat systemic infections or immune dysfunction.

- **Usage and dosage**: Systemic use requires guidance from a doctor. Oral dosage forms are rare, usually in the form of injection or topical application. The specific dosage and course of treatment need to be adjusted according to individual differences, severity of the disease and treatment response.

#### Notes:

- **Allergic reactions**: Although LL-37 is generally safe, it may still cause allergic reactions, especially in patients with allergic constitutions. Therefore, monitor for allergic symptoms such as redness, swelling, and itching when using it.

- **Long-term use**: Long-term use of LL-37 may lead to drug resistance in some microorganisms, so it is recommended to use it according to the course of treatment and avoid excessive use.

 

### 4. **Summary**

LL-37, as a natural antimicrobial peptide, has a wide range of immunomodulatory, antibacterial, antiviral, anti-inflammatory, and wound healing effects. It is suitable for patients with low immune function, chronic inflammation, skin infections, etc. Usage and dosage should be adjusted according to the patient's condition and the doctor's advice to achieve the best therapeutic effect.

10

 

Advantages of peptide LL37

 

LL-37 (Cathelicidin LL-37) is a natural antimicrobial peptide belonging to the human antimicrobial peptide family. It has multiple biological functions. In addition to antimicrobial effects, it is also involved in multiple physiological processes such as immune regulation, wound healing, and anti-inflammation. LL-37 is mainly synthesized by cells such as neutrophils, monocytes, and keratinocytes in peripheral blood, and it has important physiological effects in the skin, lungs, gastrointestinal tract, and other parts. The following are several major benefits of LL-37:

 

### 1. **Antibacterial effect**

LL-37 has a broad-spectrum antibacterial effect and can fight bacteria, viruses, fungi, and certain parasites. It inhibits the growth and reproduction of pathogens by destroying the structure of the cell membrane of pathogens. The antibacterial mechanism of LL-37 includes:

- **Membrane destruction**: LL-37 interacts with the cell membrane of pathogens, destabilizes the membrane structure, causes the leakage of cell contents, and kills pathogenic microorganisms.

- **Immune response regulation**: LL-37 can regulate local immune responses and enhance the activity of local immune cells, such as macrophages, dendritic cells and T cells, thereby helping to clear pathogens.

 

### 2. **Anti-inflammatory effect**

LL-37 plays an important role in regulating immune responses and controlling inflammatory responses. It has the ability to inhibit excessive inflammatory responses, especially in chronic inflammatory states. Its anti-inflammatory mechanisms include:

- **Inhibition of cytokine release**: LL-37 regulates the secretion of proinflammatory cytokines, such as TNF-α, IL-6, etc., by binding to certain receptors in the immune system, thereby reducing inflammatory responses.

- **Balanced immune response**: It can promote the immune tolerance of T cells in inflammatory responses and avoid excessive immune responses from causing damage to the body.

 

### 3. **Promote wound healing**

LL-37 also plays a vital role in wound repair. Studies have found that LL-37 can accelerate the wound healing process, and its mechanisms include:

- **Stimulate the migration and proliferation of keratinocytes and fibroblasts**: LL-37 helps repair damaged tissues by promoting the proliferation and migration of skin basal cells.

- **Promote angiogenesis**: LL-37 can promote the proliferation and migration of vascular endothelial cells, help blood vessels to re-form during wound healing, and improve local blood supply.

- **Antibacterial effect**: By inhibiting wound infection, LL-37 reduces complications caused by bacterial infection of wounds and further promotes healing.

 

### 4. **Immunomodulatory effect**

LL-37 not only plays a role in local immunity, but also plays an important role in systemic immunity. It regulates immune responses through multiple mechanisms, including:

- **Regulates innate immune responses**: LL-37 can activate cells of the innate immune system, such as macrophages and dendritic cells, by interacting with Toll-like receptors (TLRs), enhancing defense against pathogens.

- **Promote antigen presentation**: LL-37 can enhance the antigen presentation function of dendritic cells and help initiate adaptive immune responses.

- **Regulate Th1/Th2 balance**: LL-37 participates in regulating the balance of Th1 and Th2 cells to combat overreaction or underreaction of the immune system.

 

### 5. **Antiviral effect**

LL-37 also has certain potential in antiviral effects, especially in dealing with certain viruses such as influenza virus and SARS-CoV-2. LL-37 inhibits viral replication through multiple pathways:

- **Directly bind to viruses**: LL-37 can directly bind to virus particles to prevent the virus from binding to and invading host cells.

- **Inhibit the spread of viruses**: LL-37 reduces viral load by inhibiting the replication process of viruses in host cells.

- **Activate antiviral immune response**: LL-37 can promote the activation of local immune cells and enhance the immune response to viruses.

 

### 6. **Anti-cancer effect**

Studies have shown that LL-37 may also play a role in the occurrence and development of cancer. Its anti-cancer mechanism is mainly reflected in:

- **Inhibit tumor cell proliferation**: LL-37 may inhibit the proliferation and migration of tumor cells by binding to receptors on the surface of tumor cells.

- **Regulate the tumor microenvironment**: LL-37 helps enhance the anti-tumor immune response by changing the immune response in the tumor microenvironment.

- **Promote apoptosis of cancer cells**: Some studies have shown that LL-37 can induce apoptosis in certain types of cancer cells, thereby inhibiting the development of tumors.

 

### 7. **Skin health**

LL-37 is of great significance in the defense of the skin. It not only plays a role in antibacterial and anti-inflammatory aspects, but also helps maintain the barrier function of the skin and prevent the invasion of harmful substances from the outside. The skin health effects of LL-37 include:

- **Prevent skin infection**: LL-37 can effectively prevent the invasion of microorganisms such as bacteria and fungi by enhancing the defense function of the skin surface.

- **Improve skin barrier function**: LL-37 can promote the proliferation and differentiation of keratinocytes, which helps maintain the barrier function of the skin.

- **Relieve skin inflammation**: By regulating the skin's immune response, LL-37 can effectively relieve inflammation caused by skin diseases (such as eczema, psoriasis, etc.).

 

### 8. **Anti-aging effects**

The anti-aging effects of LL-37 may be related to its protective effect on cells, promoting cell repair and reducing oxidative stress. Studies have shown that LL-37 can:

- **Slow down skin aging**: LL-37 delays the skin aging process by reducing free radical damage and increasing the repair capacity of skin cells.

- **Improve skin hydration**: LL-37 can enhance skin barrier function, improve skin hydration, and reduce water loss.

 

### 9. **Negative regulation of the immune system**

Although LL-37 has many benefits, some studies have found that in some cases, LL-37 may have a negative impact on the immune system, especially in cases of immune overactivation:

- **Triggering excessive immune response**: In some autoimmune or allergic diseases, LL-37 may promote excessive activation of inflammatory responses, leading to tissue damage.

- **Aggravates chronic inflammation**: In some chronic inflammatory diseases, excessive concentrations of LL-37 may aggravate inflammatory responses and affect the progression of the disease.

 

### Summary

LL-37 is a multifunctional antimicrobial peptide with powerful antibacterial, anti-inflammatory, immunomodulatory, and wound healing activities. It not only plays a role in defending against external pathogens and promoting wound repair, but may also have potential therapeutic effects on cancer, aging, etc. However, LL-37 may also have a negative impact on the immune system in some cases, so caution is needed when using it.

18

 

Contact Details(WhatsApp  Telegram ) And Payment Methods

 

WhatsApp/Telegram:+852 6749 2648

Gmail:lucasraws207@gmail.com

Skype:live:.cid.8f21dc7fc6621ba7

1729737702523 1729737641865 product-570-257

 

FAQ

Q: What is LL-37?

A: LL-37 is an antimicrobial peptide composed of 37 amino acids. It belongs to the class of α-helical peptides and can effectively interact with a variety of microorganisms, such as bacteria, fungi and viruses. LL-37 plays an important role in many immune responses. In addition to its antimicrobial activity, it also plays a role in immunomodulation, wound healing, inflammatory response and cell proliferation.

Q: What is the prospect of clinical application of LL-37?

A: Although LL-37 exhibits a variety of biological activities, its clinical application as a drug is still in the research stage. The main challenges faced include:
- **Stability and toxicity issues**: LL-37 exhibits strong antibacterial and immunomodulatory effects in vitro, but its stability in vivo is relatively poor and may be affected by degrading enzymes. To solve this problem, researchers are developing a modified version of LL-37 to increase its stability and half-life.
- **Production cost and formulation issues**: The synthesis process of LL-37 is relatively complicated and costly, and its application in pharmaceutical preparations needs to overcome the problem of low bioavailability. Scientists are studying more efficient production methods, as well as enhancing their distribution and efficacy in the body through means such as nanotechnology.

 

Hot Tags: peptides ll37 5mg cas:154947-66-7, China peptides ll37 5mg cas:154947-66-7 manufacturers, suppliers, factory, TB500 CAS 885340 08 9, PEG MGF CAS 62031 54 3, GDF-8, ACE 031 Add muscle mass and volume, PT141 Improve training passion and endurance, Follistatin 344 and Fst 344

Send Inquiry
Auctus Steroid Pharma Co., Ltd
Provide a complete after-sales service guarantee, including product return and exchange policies, quality assurance, etc.
contact us